Senior Investigator
National Cancer Institute
Bethesda, Maryland, United States
Dr Aldape is a neuropathologist and Chief of the Laboratory of Pathology at the National Cancer Institute
at the National Institute of Health in Bethesda, Maryland. He focusses on genomics and molecular
diagnostics of primary brain tumors, especially gliomas, focusing on the integration of biologic tumor
signatures into clinical use for brain tumor classification. He has approximately 500 peer-reviewed
publications, several grants and is the recipient of several awards. He is a member of the WHO and c-IMPACT
groups involved in the classification of brain tumors and is actively involved in updating the classification
as new data emerge from technologies such as methylation profiling that can improve how we
understand these tumors on a biological basis.
(NC5504) DNA Methylation and IDH Profiling
Monday, April 24, 2023
7:35am – 8:04am PST
Disclosure(s): No financial relationships to disclose